Product Information

LITHIUM CARBONATE ER 300 MG TB is a generic product labeled by Heritage Pharmaceuticals Inc., priced at $0.1865 per EA under NDC 23155076301. Its NADAC has been published 302 times since Feb 10, 2021.

FDA first approved this application on Sep 29, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LITHIUM CARBONATE ER 300 MG TB

Lithium carbonate
$0.1865per EA

Strength

300 mg/1

NDC

23155076301

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

LITHIUM CARBONATE

Approval Type

Generic (ANDA)

FDA Application

ANDA205532

FDA Approved

9/29/2016

TE Code

AB

On Market Since

10/20/2020

Pharmacological Classes

Price Statistics

The NADAC for LITHIUM CARBONATE ER 300 MG TB has been published 302 times since Feb 10, 2021, and over the history we have for it it has risen 10.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1865 per EA
All-time high$0.2271 (Nov 13, 2024)
All-time low$0.1260 (Dec 21, 2022)
52-week high$0.2097
52-week low$0.1865
Median price$0.1640
Average price$0.1723
Largest weekly change+33.8% (Jun 19, 2024)
Weeks tracked302
Tracking sinceFeb 10, 2021

Price History

1W

-3.1%

1M

-5.0%

3M

-4.8%

6M

-10.1%

1Y

-10.3%

3Y

+27.1%

5Y

+11.7%

All

+10.5%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Lithium carbonate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LITHIUM CARBONATE ER 300 MG TB?

The current National Average Drug Acquisition Cost (NADAC) for LITHIUM CARBONATE ER 300 MG TB, manufactured by Heritage Pharmaceuticals Inc., is $0.1865 per EA (NDC 23155076301), effective Nov 18, 2026.

How has the price of LITHIUM CARBONATE ER 300 MG TB changed over time?

Over the history we have for it, the NADAC for LITHIUM CARBONATE ER 300 MG TB has risen 10.5%. It has been tracked across 302 weekly CMS publications since Feb 10, 2021.

What are the highest and lowest recorded NADAC prices for LITHIUM CARBONATE ER 300 MG TB?

Since Feb 10, 2021, the NADAC for LITHIUM CARBONATE ER 300 MG TB has ranged from a low of $0.1260 (Dec 21, 2022) to a high of $0.2271 (Nov 13, 2024), with a median of $0.1640 per EA.

Are there cheaper alternatives to LITHIUM CARBONATE ER 300 MG TB?

No other NADAC-published product currently shares the active ingredient and strength of LITHIUM CARBONATE ER 300 MG TB in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures LITHIUM CARBONATE ER 300 MG TB?

LITHIUM CARBONATE ER 300 MG TB (NDC 23155076301) is labeled by Heritage Pharmaceuticals Inc., and CMS classifies it as a generic product.